The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-07
DOI
10.1038/s41380-019-0511-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
- (2018) Davide Amato et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
- (2018) Diego Scheggia et al. Nature Communications
- Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders
- (2017) C. Prats et al. EUROPEAN PSYCHIATRY
- D3 Receptors Regulate Excitability in a Unique Class of Prefrontal Pyramidal Cells
- (2017) Rebecca L. Clarkson et al. JOURNAL OF NEUROSCIENCE
- Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex
- (2017) D Scheggia et al. MOLECULAR PSYCHIATRY
- Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder
- (2017) M. Mereu et al. NEUROPHARMACOLOGY
- Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade
- (2017) Sebastiano Alfio Torrisi et al. Frontiers in Pharmacology
- The dopamine D3 receptor, a quarter century later
- (2016) Pierre Sokoloff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dysbindin-1 modifies signaling and cellular localization of recombinant, human D3 and D2 receptors
- (2016) Nathalie Schmieg et al. JOURNAL OF NEUROCHEMISTRY
- Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
- (2016) Anthony A. Grace NATURE REVIEWS NEUROSCIENCE
- Current drug treatments targeting dopamine D3 receptor
- (2016) Gian Marco Leggio et al. PHARMACOLOGY & THERAPEUTICS
- Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia
- (2016) Francesca Managò et al. Cell Reports
- Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
- (2016) Samuele Maramai et al. Frontiers in Neuroscience
- Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia
- (2015) Francesco Papaleo et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs
- (2015) Emilio Merlo Pich et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis
- (2015) Yin Cui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans
- (2014) Sara Sannino et al. CEREBRAL CORTEX
- Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC
- (2014) Hirotake Hida et al. NEUROPSYCHOPHARMACOLOGY
- The Ultimate Intra-/Extra-Dimensional Attentional Set-Shifting Task for Mice
- (2013) Diego Scheggia et al. BIOLOGICAL PSYCHIATRY
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
- (2013) F Papaleo et al. MOLECULAR PSYCHIATRY
- Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice
- (2013) Huiping Huang et al. NEUROPSYCHOPHARMACOLOGY
- Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects
- (2012) Henry A. Lester et al. BIOLOGICAL PSYCHIATRY
- Synaptic Activity Unmasks Dopamine D2 Receptor Modulation of a Specific Class of Layer V Pyramidal Neurons in Prefrontal Cortex
- (2012) S. Gee et al. JOURNAL OF NEUROSCIENCE
- Use-Dependent Inhibition of Synaptic Transmission by the Secretion of Intravesicularly Accumulated Antipsychotic Drugs
- (2012) Carsten H. Tischbirek et al. NEURON
- Update: Studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome
- (2012) Neal R. Swerdlow NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?
- (2011) K O Schubert et al. MOLECULAR PSYCHIATRY
- Mouse models of genetic effects on cognition: Relevance to schizophrenia
- (2011) Francesco Papaleo et al. NEUROPHARMACOLOGY
- Dysbindin and Schizophrenia: It's Dopamine and Glutamate All Over Again
- (2010) Francesco Papaleo et al. BIOLOGICAL PSYCHIATRY
- Dopamine D3Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1
- (2010) Dawn Thompson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Projection-Specific Neuromodulation of Medial Prefrontal Cortex Neurons
- (2010) N. C. Dembrow et al. JOURNAL OF NEUROSCIENCE
- Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways
- (2010) F Papaleo et al. MOLECULAR PSYCHIATRY
- Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
- (2009) Kwang H Choi et al. BMC Psychiatry
- Role of dysbindin in dopamine receptor trafficking and cortical GABA function
- (2009) Y. Ji et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
- (2009) M. van den Buuse SCHIZOPHRENIA BULLETIN
- Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype?
- (2008) Alan E. Ceaser et al. BIOLOGICAL PSYCHIATRY
- On the historical and conceptual background of the Wisconsin Card Sorting Test
- (2008) Paul Eling et al. BRAIN AND COGNITION
- Genetic Dissection of the Role of Catechol-O-Methyltransferase in Cognition and Stress Reactivity in Mice
- (2008) F. Papaleo et al. JOURNAL OF NEUROSCIENCE
- Habituation and sensitization of acoustic startle: Opposite influences of dopamine D1 and D2-family receptors
- (2008) Adam L. Halberstadt et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells
- (2007) Peter Heusler et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now